116 related articles for article (PubMed ID: 9449234)
1. Proadrenomedullin N-terminal 20-peptide (PAMP) receptors and signal transduction in the rat adrenal gland.
Hinson JP; Hagi-Pavli E; Thomson LM; Kapas S
Life Sci; 1998; 62(5):439-43. PubMed ID: 9449234
[TBL] [Abstract][Full Text] [Related]
2. Proadrenomedullin N-terminal 20 peptide (PAMP), acting through PAMP(12-20)-sensitive receptors, inhibits Ca2+-dependent, agonist-stimulated secretion of human adrenal glands.
Belloni AS; Rossi GP; Andreis PG; Aragona F; Champion HC; Kadowitz PJ; Murphy WA; Coy DH; Nussdorfer GG
Hypertension; 1999 May; 33(5):1185-9. PubMed ID: 10334809
[TBL] [Abstract][Full Text] [Related]
3. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat.
Iwasaki H; Hirata Y; Iwashina M; Sato K; Marumo F
Endocrinology; 1996 Jul; 137(7):3045-50. PubMed ID: 8770930
[TBL] [Abstract][Full Text] [Related]
4. Proadrenomedullin N-terminal 20 peptide (PAMP) stimulates aldosterone secretion by the intact rat adrenal glomerulosa by a cAMP-dependent mechanism.
Thomson LM; Kapas S; Hinson JP
FEBS Lett; 1998 Jul; 432(1-2):37-9. PubMed ID: 9710246
[TBL] [Abstract][Full Text] [Related]
5. Regulation of PAMP and adrenomedullin receptor expression in the rat adrenal zona glomerulosa.
Kapas S; Thomson LM; Hinson JP
Endocr Res; 1998; 24(3-4):717-20. PubMed ID: 9888564
[TBL] [Abstract][Full Text] [Related]
6. Adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP) in adrenal chromaffin cells.
Kobayashi H; Yanagita T; Yokoo H; Wada A
Peptides; 2001 Nov; 22(11):1895-901. PubMed ID: 11754978
[TBL] [Abstract][Full Text] [Related]
7. Effects of adrenomedullin and proadrenomedullin N-terminal 20 peptide on rat zona glomerulosa cells.
Andreis PG; Mazzocchi G; Rebuffat P; Nussdorfer GG
Life Sci; 1997; 60(19):1693-7. PubMed ID: 9129124
[TBL] [Abstract][Full Text] [Related]
8. Role of adrenomedullin and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis.
Nussdorfer GG; Rossi GP; Mazzocchi G
Peptides; 1997; 18(7):1079-89. PubMed ID: 9357070
[TBL] [Abstract][Full Text] [Related]
9. Proadrenomedullin N-terminal 20 peptide inhibits aldosterone secretion of human adrenocortical and Conn's adenoma cells: comparison with adrenomedullin effect.
Andreis PG; Tortorella C; Mazzocchi G; Nussdorfer GG
J Clin Endocrinol Metab; 1998 Jan; 83(1):253-7. PubMed ID: 9435451
[TBL] [Abstract][Full Text] [Related]
10. Decrease of TSH levels and epithelium/colloid ratio in rat thyroid glands following administration of proadrenomedullin N-terminal peptide (12-20).
Ginda WJ; Nowak KW; Malendowicz LK
Horm Metab Res; 2000 Jan; 32(1):10-4. PubMed ID: 10727007
[TBL] [Abstract][Full Text] [Related]
11. Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides.
Kamohara M; Matsuo A; Takasaki J; Kohda M; Matsumoto M; Matsumoto S; Soga T; Hiyama H; Kobori M; Katou M
Biochem Biophys Res Commun; 2005 May; 330(4):1146-52. PubMed ID: 15823563
[TBL] [Abstract][Full Text] [Related]
12. [Adrenomedullin and PAMP].
Kitamura K; Eto T
Nihon Rinsho; 1997 Aug; 55(8):1963-70. PubMed ID: 9284408
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the effect of different regulatory peptides on adrenocortical cell proliferation in immature rats: evidence that endogenous adrenomedullin exerts a stimulating action.
Trejter M; Markowska A; Belloni AS; Nussdorfer GG; Malendowicz LK
Int J Mol Med; 2002 Jul; 10(1):81-4. PubMed ID: 12060855
[TBL] [Abstract][Full Text] [Related]
14. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla.
Kuwasako K; Kitamura K; Ichiki Y; Kato J; Kangawa K; Matsuo H; Eto T
Biochem Biophys Res Commun; 1995 Jun; 211(2):694-9. PubMed ID: 7794284
[TBL] [Abstract][Full Text] [Related]
15. Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat.
Inatsu H; Sakata J; Shimokubo T; Kitani M; Nishizono M; Washimine H; Kitamura K; Kangawa K; Matsuo H; Eto T
Biochem Mol Biol Int; 1996 Feb; 38(2):365-72. PubMed ID: 8850532
[TBL] [Abstract][Full Text] [Related]
16. Expression of proadrenomedullin derived peptides in the mammalian pituitary: co-localization of follicle stimulating hormone and proadrenomedullin N-20 terminal peptide-like peptide in the same secretory granules of the gonadotropes.
Montuenga LM; Burrell MA; Garayoa M; Llopiz D; Vos M; Moody T; García-Ros D; Martínez A; Villaro AC; Elsasser T; Cuttitta F
J Neuroendocrinol; 2000 Jul; 12(7):607-17. PubMed ID: 10849205
[TBL] [Abstract][Full Text] [Related]
17. Proadrenomedullin NH(2)-terminal 20 peptide (PAMP) and adrenomedullin bind to teratocarcinoma cells.
Moody TW; Coy D; Cuttitta F; Montuenga LM
Peptides; 2000 Jan; 21(1):101-7. PubMed ID: 10704725
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP-dependent synthesis and release of adrenomedullin and proadrenomedullin N-terminal 20 peptide in cultured bovine adrenal chromaffin cells.
Kobayashi H; Yamamoto R; Kitamura K; Niina H; Masumoto K; Minami SI; Yanagita T; Izumi F; Aunis D; Eto T; Wada A
Eur J Biochem; 1999 Aug; 263(3):702-8. PubMed ID: 10469133
[TBL] [Abstract][Full Text] [Related]
19. [Effects of adrenomedullin and proadrenomedullin N-terminal 20 peptide, alone or in combination, on the rat hearts in vitro].
Yang J; Li J; Geng B; Ren Y; Tang C
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Dec; 35(6):561-5. PubMed ID: 14710244
[TBL] [Abstract][Full Text] [Related]
20. Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide: its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla.
Katoh F; Kitamura K; Niina H; Yamamoto R; Washimine H; Kangawa K; Yamamoto Y; Kobayashi H; Eto T; Wada A
J Neurochem; 1995 Jan; 64(1):459-61. PubMed ID: 7798947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
